2000•GastroenterologyOpen access

Effect of genetic differences in CYP2C19 on cure rates for helicobacter pylori infection by a triple therapy with proton pump inhibitor, amoxicillin, and clarithromycin

Takahisa Furuta, Naohito Shirai, Misako Takashima, Xiao Fang, Hiroyuki Hanai, Kyoichi Ohashi, Takashi Ishizaki

Open full text 5 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Clarithromycin, CYP2C19, Helicobacter pylori, Proton-pump inhibitor, Amoxicillin, Medicine, Rabeprazole, Helicobacter pylori infection

Back to paper search Browse research topics Original source

Effect of genetic differences in CYP2C19 on cure rates for helicobacter pylori infection by a triple therapy with proton pump inhibitor, amoxicillin, and clarithromycin — Research Paper | ScholarLens